Patrick Weiss - 03 Jan 2022 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Reporting relationship: Chief Operating Officer
Issuer ticker: TWST
Reported as of: 03 Jan 2022
Net transaction value: -$18,728
SEC form: 4
Accepted by SEC: 05 Jan 2022, 15:35:28 UTC
Prior SEC filing: 29 Dec 2021
Next SEC filing: 20 Jan 2022
Source filing: View source filing
Reporting owner signature: /s/ William Solis, as Attorney-in-Fact for Patrick Weiss

Filing notes and source

Key filing fact

Patrick Weiss filed Form 4 for Twist Bioscience Corp (TWST) on 05 Jan 2022.

Key facts

This page summarizes Patrick Weiss's Form 4 filing for Twist Bioscience Corp (TWST).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Jan 2022, 15:35.

Change

Previous filing in this sequence was filed on 29 Dec 2021.
Current net transaction value: -$18,728.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TWST transaction

Common Stock

Tax liability

Transaction value: -$18,728
Shares: -242
Change %: -0.49%
Price: $77.39
Shares after: 49,385
Date: 03 Jan 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).